Literature DB >> 8131202

Dupuytren's contracture in black Zimbabweans.

G I Muguti1, B Appelt.   

Abstract

Four cases of Dupuytren's contracture treated at Mpilo Central Hospital over the last 13 years are presented. Three of these patients were men aged 45, 59 and 74 years. Only one woman aged 55 years was treated during this period. All the four patients were indigenous Black Zimbabweans. There was some history of trauma to the affected upper limb in all three of the male patients and all of them agreed to being moderate smokers but only two gave a history of drinking alcohol. One of the men had been treated for pulmonary tuberculosis. The female patient has been on treatment for epilepsy for more than 10 years. There was no family history of Dupuytren's contracture in any of these patients. Although Dupuytren's contracture is generally considered to be a European disease this report and a few isolated case reports confirm that this condition occurs in indigenous Black Africans.

Entities:  

Mesh:

Year:  1993        PMID: 8131202

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  4 in total

1.  Genome-wide association scan of Dupuytren's disease.

Authors:  Joshua O Ojwang; Indra Adrianto; Courtney Gray-McGuire; Swapan K Nath; Celi Sun; Kenneth M Kaufman; John B Harley; Ghazi M Rayan
Journal:  J Hand Surg Am       Date:  2010-10-25       Impact factor: 2.230

2.  Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Authors:  Sandip Hindocha; Duncan Angus McGrouther; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-15

3.  Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants.

Authors:  Sophie A Riesmeijer; Paul M N Werker; Ilja M Nolte
Journal:  Eur J Hum Genet       Date:  2019-07-30       Impact factor: 4.246

4.  Dupuytren's disease in Bosnia and Herzegovina. An epidemiological study.

Authors:  Dragan Zerajic; Vilhjalmur Finsen
Journal:  BMC Musculoskelet Disord       Date:  2004-03-29       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.